TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/30/20 06:00 | 12/29/20 | TCON | Tracon Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggins Mark C | CA | O | Chief Bu | P | 11 | 10.57 | 0 | 1 | 8 | 14 | D | ||||||||||||||
9/14/20 13:49 | 9/10/20 | TCON | Tracon Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggins Mark C | CA | O | Chief Bu | P | 29 | 4.14 | 0 | 7 | 131 | 12 | D | ||||||||||||||
3/24/20 16:38 | 3/23/20 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wiggins Mark C | CA | D | P | 51 | 20.48 | 0 | 3 | New | 3 | D | |||||||||||||||
1/24/20 16:10 | 1/23/20 | TCON | Tracon Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wiggins Mark C | CA | O | Chief Bu | P | 20 | 4.02 | 0 | 5 | New | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |